Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A12 | Q96S37 | 15/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | XDH | P47989 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22908052 | 0.95 | SLC22A12 (0.41) | SLC22A12XDHALDH1A1KDM4E | |
| SCHEMBL22908011 | 0.93 | SLC22A12 (0.45) | SLC22A12CYP11B1CYP11B2ALDH1A1KDM4E | |
| SCHEMBL22065338 | 0.89 | SLC22A12 (0.48) | SLC22A12CYP11B1CYP11B2ALDH1A1KDM4E | |
| SCHEMBL19939315 | 0.89 | MAPT (0.41) | SLC22A12CYP11B1CYP11B2XDHALDH1A1 | |
| SCHEMBL22064790 | 0.86 | ABCG2 (0.48) | SLC22A12ALDH1A1LMNA | |
| SCHEMBL19939351 | 0.85 | ESR2 (0.44) | SLC22A12XDHALDH1A1KDM4E | |
| SCHEMBL21658277 | 0.85 | ABCG2 (0.45) | SLC22A12ALDH1A1LMNA | |
| SCHEMBL19939330 | 0.85 | ESR2 (0.44) | SLC22A12XDHALDH1A1KDM4E | |
| SCHEMBL21658388 | 0.85 | ABCG2 (0.47) | SLC22A12CYP11B2ALDH1A1LMNA | |
| SCHEMBL22064797 | 0.84 | ESR2 (0.40) | SLC22A12XDHALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210305516-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-09-30 | — | — | US | disclosed |
| US-20210210694-A1 | ORGANIC LIGHT EMITTING DIODE | LG CHEM, LTD. (KR) | 2021-07-08 | — | — | US | disclosed |
| US-20210143344-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
| US-10950801-B2 | Organic light-emitting device | LG CHEM, LTD. (KR) | 2021-03-16 | — | — | US | disclosed |
| US-20210020842-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-01-21 | — | — | US | disclosed |
| US-20200287142-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM LTD. (KR) | 2020-09-10 | — | — | US | disclosed |
| US-20200181096-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2020-06-11 | — | — | US | disclosed |
| WO-2020022771-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2020-01-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210305516-A1 | ORGANIC LIGHT-EMITTING DEVICE | AOC2, RUVBL2, RUVBL1 | SLC22A12 1431/4885CYP11B1 786/4885CYP11B2 656/4885 |
| US-20200181096-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CYP1A1, AHR | SLC22A12 4126/4885CYP11B1 483/4885CYP11B2 701/4885 |
| US-20210020842-A1 | ORGANIC LIGHT-EMITTING DEVICE | OR10J3, OR51E2, LOXL1 | SLC22A12 1976/4885CYP11B1 706/4885CYP11B2 359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.